Global Aptamers Market By Type Overview
Aptamers Market was valued at US$ 2.9 Billion in 2024 and is projected to grow at a CAGR of 24.7% to reach US$ 26.6 Billion by 2034.
Aptamers are short, single-stranded DNA or RNA (ssDNA or ssRNA) molecules, which can selectively bind to a specific target, including peptides, proteins, small molecules, carbohydrates, toxins, and even live cells. Aptamers assume various shapes, owing to their tendency to form helices or single-stranded loops. These molecules are extremely versatile and are used to bind targets with high specificity and selectivity. Aptamers are generated rapidly and applied in the inhibition, specific detection, and characterization of proteins. Aptamers can be used as detection reagents, pharmaceutical leads, and functional proteomic levels with antibodies, small molecules, and other aptamers.
The Aptamers Market accounted for US$ 205.40 million in 2020 and is estimated to be US$ 985.44 million by 2030 and is anticipated to register a CAGR of 16.90%.
Global Aptamers Market By Type Drivers & Restraints
Advancements in aptamer development technologies
Advancements in aptamer development technologies, increasing R&D expenditure, and the rising number of companies investing in this market are some of the major key driving factors responsible for the growth of the global aptamers market. Low cost and high efficacy in binding to large molecules compared to antibodies and the patent expiration of systemic evolution of ligands by exponential enrichment technology (SELEX) will boost the global market positively. They are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. Along with this, continuous advancement in technologies is expected to stimulate growth of global aptamers market. However, many aptamers have failed to meet the requisite safety and efficacy standards in clinical studies. Thus, companies have to terminate their clinical investigation during late-stage clinical studies. This factor is likely to affect the growth of the global market negatively. In addition, other factors, such as low awareness about these technologies in middle and low-income countries and inadequate regulatory structure, may hamper the overall growth of the global market.
Due to increasing adoptions of aptamers
Whereas, due to increasing adoptions of aptamers in chemical and food industries are expected to provide growth opportunities for the stakeholders involved in the global aptamers market. Growing demand among public for the aptamers due to benefits such as their high efficiency and low cost compared to antibodies are the factors that are expected to provide opportunity for the global market growth.
Global Aptamers Market By Type Segmentations & Regional Insights
Based on type, the aptamers market is segmented into the nucleic acid, and peptides. The peptides is further classified into DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. On the basis of type, the DNA based aptamers segment is expected to account highest revenue share due to increasing initiatives in research and development. On the basis of application, the global market is bifurcated into diagnostics, therapeutics, and research and development. Based on application, the diagnostic segment has expected to grow high due to a constantly increasing population with various diseases leading to boost in demand for various diagnostic techniques.
Regional Insights:
For detailed understanding of market dynamics, Based on the region the global aptamers market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the global aptamers market due to rapid technological advancements and high investment and funding to support the development of aptamers. Asia-Pacific is also expected to propel the global aptamers market, owing to factors, such as increasing research & development activities and economic growth.
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Million & CAGR from 2024 – 2034 |
|
Market Segmentation |
By Type: Monovalent and Polyvalent By Animal Type: Snake, Scorpion, Spider and Others By Distribution Channel: Hospital, Retail Pharmacies and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Aptamers Market, By Type:
- Nucleic Acid
- Peptides
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
Aptamers Market, By Application:
- Diagnostics
- Therapeutics
- Research and Development
Aptamers Market, By Region:
- North America
- Middle East & Africa
- Middle East & Africa Aptamers Market, By Type
- Middle East & Africa Aptamers Market, By Application
- Middle East & Africa Aptamers Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Latin America Aptamers Market, By Type
- Latin America Aptamers Market, By Application
- Latin America Aptamers Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- Asia Pacific Aptamers Market, By Type
- Asia Pacific Aptamers Market, By Application
- Asia Pacific Aptamers Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Europe
- Europe Aptamers Market, By Type
- Europe Aptamers Market, By Application
- Europe Aptamers Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- North America Aptamers Market, By Type
- North America Aptamers Market, By Application
- North America Aptamers Market, By Country
- U.S.
- Canada
- Middle East & Africa
Global Aptamers Market By Type Competitive Landscape & Key Players
The key players operating the aptamers market involves Somalogic, Inc., Noxxan Pharma AG, Aptamer Science Inc., Aptagen, Inc, AM Biotechnologies LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., TriLink BioTechnologies, Inc. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market. For instance, in February 2019, Base Pair Biotechnologies INC. has developed the point0of-care tests to diagnose neonatal abstinence syndrome based on aptamer with the assistance of the SBIR grant.
Global Aptamers Market By Type Company Profile
- Boston Scientific Corporation
- TriLink BioTechnologies, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- NeoVentures Biotechnology Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Base Pair Biotechnologies Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Aptus Biotech S.L.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Aptamer Solutions Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- AM Biotechnologies LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Aptagen, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Aptamer Science Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Noxxan Pharma AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Somalogic Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- TriLink BioTechnologies, Inc.
Global Aptamers Market By Type Highlights
FAQs
The global aptamers market is segmented based on type, application, and region.
Advancements in aptamer development technologies, increasing R&D expenditure, and the rising number of companies investing in this market are some of the major key driving factors responsible for the growth of the global aptamers market.
North America accounts highest revenue share to the global aptamers market due to rapid technological advancements and high investment and funding to support the development of aptamers.
The key players operating the global aptamers market involves Somalogic, Inc., Noxxan Pharma AG, Aptamer Science Inc., Aptagen, Inc, AM Biotechnologies LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., TriLink BioTechnologies, Inc.